SPY317.05+4.82 1.54%
DIA263.00+4.58 1.77%
IXIC10,433.65+226.02 2.21%

Matinas BioPharma Hldgs Q3 EPS $(0.03), Inline

Matinas BioPharma Hldgs (NYSE:MTNB) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is unchanged from the same period last year.

Benzinga · -

Matinas BioPharma Hldgs (NYSE:MTNB) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is unchanged from the same period last year.